Purchase Order 75N92E23P00020
- Not listed
- The Department of Health and Human Services' National Institutes of Health awarded a $4,570.01 firm fixed price delivery order contract to Illumina, Inc., a for-profit manufacturer of genetic sequencing systems and reagents, for the provision of Illumina MiSeq sequencing kits. The contract has no set-aside designation and was awarded on July 28, 2017, with a completion date of August 7, 2017. Illumina has a history of providing sequencing instruments, consumables, and services to support genomic...
- This is a firm fixed-price delivery order awarded by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genomic sequencing systems and analytical instruments. The contract, valued at $149,982.23, is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample preparation kits, sequencing chips, support plans, maintenance services,...
- The Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute awarded a $197,925.00 firm fixed price purchase order for an Illumina NextSeq Sequencing System to Illumina, Inc., a for-profit manufacturer of genomic analysis instruments and reagents. The purchase order was not set aside for any specific business size or type. The award is intended to support the agency's mission by providing a sequencing platform that can increase data output...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Environmental Health Sciences awarded a firm fixed price delivery order to Illumina, Inc., a manufacturer of genomic sequencing systems and bioinformatics solutions. The $44,293.79 award does not utilize a set-aside program and is intended to provide the NIH with Illumina's proprietary sequencing instruments, reagents, and related products and services to support genomic analysis research....
- The Department of Health and Human Services National Institutes of Health National Institute of Environmental Health Sciences awarded a firm fixed-price delivery order to Illumina, Inc., a for-profit manufacturer of genetic analysis and sequencing instruments and reagents. The $38,900.48 contract is to provide various Illumina sequencing systems, consumables, and support services to support genomic research and diagnostics. The order was awarded under a standing purchase quote, and there was...
- This contract was awarded by the National Human Genome Research Institute, a civilian agency, to Illumina, Inc., a for-profit manufacturer of goods. The contract is for the purchase of an Illumina MiSeq System, a genetic sequencing instrument, for $95,931.00 on a firm fixed price basis. The contract has no set-aside designation. Based on Illumina's history of federal contract awards, the company has provided a range of sequencing instruments, reagents, and bioinformatics products to support...
- This firm fixed-price delivery order was awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc. for $80,845.20. The award does not have a set-aside designation. Illumina, a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, is providing various NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, reagents, consumables, and bioinformatics products to support genomic...
- This firm fixed-price delivery order was awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing and analysis equipment. The $148,830.24 contract provides for the delivery of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample preparation kits, sequencing chips, support plans, maintenance services, and...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $13,250.00 firm fixed price purchase order contract to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis solutions. The 12-month service contract, with a period of performance from April 1, 2019 through March 31, 2020, is for Illumina's MiSeq sequencing system and related services. This award is not associated with a larger...
- This $149,519.97 firm fixed price delivery order was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Environmental Health Sciences to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The order is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample prep kits, and bioinformatics support. The contract does...
The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $19,250.00 firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of genomics and sequencing products. The contract is for a MiSeq system health check to be provided on a quarterly basis. Illumina has a history of providing sequencing instruments, reagents, and related services to federal agencies like the NIH, CDC, USDA, and VA to support genomics research and diagnostics. While this award does not have a set-aside designation, Illumina has previously been a subcontractor on larger awards through prime partners like Triad National Security and Battelle Memorial Institute. Illumina also holds an Indefinite Delivery Contract with the Department of the Navy Bureau of Medicine and Surgery to provide reagents and controls for their MiSeq, iSeq, NextSeq, and NovaSeq6000 sequencing platforms used for biological threat characterization.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.3k | 11/17/22 |